Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

Mariana Capurro, Ian R. Wanless, Morris Sherman et al. · Gastroenterology · 2003 · 907 citations · Full text

Medicine, Oncology, Pathology +16

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

Hwai‐I Yang, Man‐Fung Yuen, Henry Lik‐Yuen Chan et al. · The Lancet Oncology · 2011 · 660 citations · Full text

Medicine, Biostatistics, Oncology +14

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker

Tetsuya Nakatsura, Yoshihiro Yoshitake, Satoru Senju et al. · Biochemical and Biophysical Research Communications · 2003 · 432 citations

Medicine, Cancer Biology, Oncology +14

Glypicans: proteoglycans with a surprise

Jorge Filmus, Scott B. Selleck · Journal of Clinical Investigation · 2001 · 359 citations · Full text

Life Sciences, Biochemistry, Microbiology +8

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

Naoko Yamauchi, Akira Watanabe, Michiyo Hishinuma et al. · Modern Pathology · 2005 · 338 citations · Full text

Medicine, Biochemistry, Oncology +17